Ferring Pharmaceuticals: all 254 studies
Page 3 of 3. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate CancerCompletedNCT01491971Phase 2
- A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With ConstipationCompletedNCT01474499Phase 3
- Prospective, Longitudinal Multicentric Survey in the Therapeutic Care of Mild to Moderate Ulcerative ColitisCompletedNCT01387698
- A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1CompletedNCT01373606Phase 1/2
- MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal EnuresisCompletedNCT01368913
- Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTONCompletedNCT01365351
- User Surveillance in Ulcerative ColitisCompletedNCT01363453
- Retrospective Data Analysis in Crohn's DiseaseCompletedNCT01363427
- Assessment of the Effectiveness of Menopur in Intrauterine InseminationCompletedNCT01354834
- Adipocyte Function and Somtropin DeficiencyCompletedNCT01351818
- Follow-up of Glypressin (Terlipressin) Clinical Efficacy in the Treatment of Bleeding Oesophageal VaricesCompletedNCT01335516
- Investigation of KLYX in Patients With ConstipationCompletedNCT01335386Phase 2
- Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH AntagonistCompletedNCT01331733
- Assessment of the Effectiveness and Tolerability of Ovarian HyperstimulationCompletedNCT01331720
- Assessment of the Therapeutic Utility of hMG-HPCompletedNCT01330784
- Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HPCompletedNCT01330771
- Evaluation of Overall Compliance and Duration of Zomacton® Treatment With the Zomajet® Needle-free DeviceCompletedNCT01306357
- A Study of PICOPREP in Patients Needed to Clean the Bowel Prior to X-ray Examination, Endoscopy or Surgery.CompletedNCT01292109
- A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).CompletedNCT01280188Phase 3
- A Study of Minirin Melt in Patients With NocturiaCompletedNCT01222598
- Compliance and Efficacy in the Use of PICOPREP®CompletedNCT01220453
- A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate CancerCompletedNCT01215526
- A Study of Minirin Melt in Patients With NocturiaCompletedNCT01212224
- Post Marketing Surveillance of MENOPURCompletedNCT01202123
- Open Label Comparative Trial of Dinoprostone Plus or Minus Oxytocin Versus Oxytocin Alone in Cervical Ripening for Labor InductionTerminatedNCT01190163Phase 4
- Quality of Life With TESTIM®CompletedNCT01148433
- A Study of Pentasa in Patients With Ulcerative ColitisCompletedNCT01104753
- Effect of Oxytocin Antagonist on Reduction of Uterine ContractionsCompletedNCT01043120Phase 2
- Single Ascending Dose Study of Oral CPSI-2364 (Semapimod)CompletedNCT00950105Phase 1
- Effectiveness and Safety of Firmagon®CompletedNCT00930319
- A Study of Zomacton in Children With Growth Hormone DeficiencyCompletedNCT00884000Phase 3
- Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile FemalesCompletedNCT00796289Phase 2
- Extension Study of Semapimod 60 mg IV x 3 DaysCompletedNCT00741910Phase 2
- Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's DiseaseCompletedNCT00740103Phase 2
- Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus PlaceboCompletedNCT00739986Phase 2
- Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis.CompletedNCT00737789Phase 3
- Open-Label, Randomised Parallel-Group StudyWithdrawnNCT00728533Phase 3
- Effect of Oxytocin and Vasopressin Antagonists on Uterine ContractionsCompletedNCT00587327Phase 2
- Pharmacokinetics and Safety of the 100 Mcg Misoprostol Vaginal Insert (MVI 100)WithdrawnNCT00528255Phase 2
- Double-Blind,Randomized,Placebo-Controlled Efficacy & Safety Study of EUFLEXXA™ for Treatment of OA of the First CMCCompletedNCT00423371Phase 2/3
- Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of LabourCompletedNCT00346840Phase 2
- Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of QuinagolideCompletedNCT00329693Phase 2
- Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)CompletedNCT00296478Phase 3
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRHCompletedNCT00296465Phase 2/3
- An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MGCompletedNCT00250250Phase 3
- The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"TerminatedNCT00245505Phase 3
- A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal EnuresisCompletedNCT00245479Phase 4
- Desmopressin Response in the YoungCompletedNCT00230594Phase 3
- A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s DiseaseCompletedNCT00225810Phase 4
- A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm LaborCompletedNCT00209326Phase 2
- Pentasa Once Daily in Ulcerative Colitis for Maintenance of RemissionCompletedNCT00209300Phase 3
- Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative ColitisTerminatedNCT00209287Phase 4
- A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)CompletedNCT00209261Phase 4
- CNI-1493 for Treatment of Moderate to Severe Crohn's DiseaseTerminatedNCT00038766Phase 2